Skip to main content

Table 1 Cell Viability

From: A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols

Viability (%)

Donor

Mean

Median

< 70%

70-100%

 

1

84.7

86.2

3 (15%)

17 (85%)

 

2

88.5

90.5

1 (5%)

19 (95%)

 

3

86.3

86.1

0 (0%)

20 (100%)

 

4

85.0

87.2

2 (10%)

18 (90%)

  1. The table reports the overall viability for each of the thawed PBMC donor samples as determined by trypan blue staining. The table presents the mean and median viability for each donor. It also reports the proportion within optimal and suboptimal ranges.
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us